Izabela D.
- Country
- Poland
- Department
- N/A
Research Overview
- Phase 4 Randomized Double-Blind Placebo-Controlled Study on Rimegepant Efficacy and Tolerability in Migraine Prophylaxis for Adults with Inadequate Oral Preventive Response
- Efficacy and Tolerability of Rimegepant in Acute Migraine Treatment for Adults Contraindicated for Triptans: A Phase 4 Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 37 of 79 partner sites.
Specializations
Headache and Migraine Medicine
Izabela Domitrz is involved in clinical research focused on migraine prevention and acute symptom control, with attention to migraine attacks with or without aura and migraine headaches with or without aura. The therapeutic interest includes treatment options for adults who have had an inadequate response to oral preventive medicines and for those requiring non-triptan acute therapy.
- Migraine prevention
- Acute migraine treatment
- Migraine with aura
- Non-triptan therapy
The research activity in this area reflects engagement with modern neurology care for recurrent headache disorders and medication-based strategies for both prevention and rapid relief.
Neuromuscular Autoimmune Disorders
Her clinical trial involvement also extends to generalized myasthenia gravis, with interest in therapies aimed at improving muscle function and addressing immune-mediated weakness. This area includes evaluation of treatments designed for symptomatic control and disease management in chronic neuromuscular autoimmunity.
- Generalized myasthenia gravis
- Muscle strength
- Autoimmune neuromuscular disease
The trial portfolio in this field supports clinical development in disorders where antibody-driven mechanisms affect neuromuscular transmission and functional mobility.
Peripheral Nerve Immune-Mediated Disease
Izabela Domitrz is active in research on chronic inflammatory demyelinating polyneuropathy (CIDP) and multifocal motor neuropathy, both of which are immune-mediated disorders affecting peripheral nerves and motor performance. The therapeutic focus centers on relapse prevention, nerve-related disability, and preservation of motor strength.
- Chronic inflammatory demyelinating polyneuropathy
- Multifocal motor neuropathy
- Relapse prevention
- Peripheral neuropathy
This area links her research to the broader field of neuroimmunology, with emphasis on therapies for chronic weakness and progressive functional impairment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.